BioDelivery Sciences International – NASDAQ: BDSI

Posted by admin in Company Profiles, Featured Articles on Mar 9th, 2009 | no responses

BioDelivery Sciences (“BDSI®“) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics.

The development strategy focuses on utilization of the FDA’s 505(b)(2) approval process to potentially obtain timely and efficient approval of new formulations of previously approved therapeutics which incorporate the company’s licensed drug delivery technologies.

Comments are closed.